Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine
NCT02283801Phase 1Completed
- Sponsor
- BIAL
- Start
- Nov 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of eslicarbazepine acetate in epilepsy (2 arms), sponsored by BIAL. Primary endpoints: Maximum Plasma Concentration at Day 27 and Area Under the Plasma Concentration-Time Curve from Time Zero to Last Sampling Time at Day 27. Started Nov 2006; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02283801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02283801.